A Case of Interstitial Pneumonitis Caused by Leflunomide
![]() ![]() |
Lee, Jung Hwa
(Hallym University College of Medicine, Department of Internal Medicine)
Cheon, Won Seok (Hallym University College of Medicine, Department of Internal Medicine) Seo, Young Il (Hallym University College of Medicine, Department of Internal Medicine) Eom, Kwang-Seok (Hallym University College of Medicine, Department of Internal Medicine) Jang, Seung Hun (Hallym University College of Medicine, Department of Internal Medicine) Bahn, Joon-Woo (Hallym University College of Medicine, Department of Internal Medicine) Kim, Dong-Gyu (Hallym University College of Medicine, Department of Internal Medicine) Jung, Ki-Suck (Hallym University College of Medicine, Department of Internal Medicine) |
1 | Silva HT, Morris RE. Leflunomide and malononitrilamides. Am J Med Sci 1997;313:289-301 DOI ScienceOn |
2 | Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blinded, randomised, multicenter trial. Lancet 1999;353:259-66 DOI PUBMED ScienceOn |
3 | Shadick NA, Fanta CH, Weinblatt M, O'Donnell W, Coblyn JS. Bronchiectasis: a late feature of severe rheumatoid arthritis. Medicine 1994;73:161-70 DOI ScienceOn |
4 | Linke SP, Clarkin KC, di Leonardo A, Tsou A, Wahl GM. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 1996;10:934-47 DOI ScienceOn |
5 | Adverse Drug Reactions Advisory Committee (ADRAC). Leflunomide: serious hepatic, blood, skin and respiratory reactions. Aust Adv Drug React Bull 2001;20:7 |
6 | Charatan F. Arthritis drug should be removed from market, says consumer group. BMJ 2002;324:869 DOI PUBMED ScienceOn |
7 | Lili LS, Mano M. Leflunomide(Arava): hematologic, hepatic and respiratory reactions. Can Adv React Newsletter 2002;12:2-3 |
8 | McCurry J. Japan deaths spark concerns over arthritis drug. Lancet 2004;363:461 |
9 | Imokawa S, Colby TV, Lesilie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000;15:373-81 DOI ScienceOn |
10 | Williamson RA, Yea CM, Robson PA, Curnock AP, Gadher S, Hambleton AB, et al. Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide. Transplant Proc 1996;28:3088-91 |
11 | Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with leflunomide compared to placebo and methotrexate. Arch Intern Med 1999;159:2542-50 DOI ScienceOn |
12 | Kim JY, Kim WU, Kim SI, Yoo WH, Park SH, Hong YS, et al. A case of methotrexate-associated interstitial pneumonitis in rheumatoid arthritis. J Korean Rheum Assoc 1998;5:126-32 |
13 | Rozman B. Clinical experience with leflunomide in rheumatoid arthritis. J Rheumatol Suppl 1998;53:27-32 |
14 | Suh HJ, Park EH, Chung MP, Shin SC, Jeon KM, Yu CM, et al. A case of hypersensitivity pneumonitis caused by methotrexate. Tuberc Respir Dis 2004;56:203-9 DOI |
![]() |